Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$74.43 - $92.22 $182,130 - $225,662
2,447 New
2,447 $201 Million
Q4 2023

Jan 25, 2024

SELL
$76.22 - $98.51 $15,244 - $19,702
-200 Reduced 6.67%
2,797 $270 Million
Q3 2023

Oct 18, 2023

SELL
$85.07 - $94.48 $8,507 - $9,448
-100 Reduced 3.23%
2,997 $265 Million
Q2 2023

Jul 20, 2023

SELL
$86.68 - $100.3 $6,501 - $7,522
-75 Reduced 2.36%
3,097 $268 Million
Q4 2022

Feb 01, 2023

BUY
$80.93 - $108.63 $256,709 - $344,574
3,172 New
3,172 $328 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Redwood Wealth Management Group, LLC Portfolio

Follow Redwood Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Wealth Management Group, LLC with notifications on news.